16 insiders reported 163 Form 4 transactions for AGIOS PHARMACEUTICALS, INC. (AGIO) over the past 18 months (most recent 2026-08-06). Recent activity: Gheuens Sarah (Chief Medical Officer) Sell 30,000 shares, Backstrom Jay T. (Director) Buy 1,447 shares, Gheuens Sarah (Chief Medical Officer) Buy 8,375 shares, Gheuens Sarah (Chief Medical Officer) Sell 4,007 shares, Smith Cynthia (Director) Buy 2,816 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-06 | Gheuens Sarah | Chief Medical Officer | Sell | 30,000 | $914,400 |
| 2026-07-10 | Backstrom Jay T. | Director | Buy | 1,447 | $0 |
| 2026-07-02 | Gheuens Sarah | Chief Medical Officer | Buy | 8,375 | $0 |
| 2026-07-02 | Gheuens Sarah | Chief Medical Officer | Sell | 4,007 | $150,503 |
| 2026-06-23 | Smith Cynthia | Director | Buy | 2,816 | $0 |
| 2026-06-23 | CAPELLO JEFFREY D | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Foster-Cheek Kaye I | Director | Buy | 2,816 | $0 |
| 2026-06-23 | FOUSE JACQUALYN A | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Ho Maykin | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Scadden David | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Ballal Rahul D. | Director | Buy | 2,816 | $0 |
| 2026-06-23 | Owen Adams Catherine | Director | Buy | 2,816 | $0 |
| 2026-06-16 | Owen Adams Catherine | Director | Buy | 1,976 | $0 |
| 2026-06-16 | CAPELLO JEFFREY D | Director | Buy | 1,976 | $0 |
| 2026-04-06 | Goff Brian | Chief Executive Officer | Buy | 25,528 | $0 |
| 2026-04-06 | Jones Cecilia | Chief Financial Officer | Buy | 8,500 | $0 |
| 2026-04-06 | Gheuens Sarah | Chief Medical Officer | Buy | 8,500 | $0 |
| 2026-04-06 | Burns James William | Chief Legal Officer | Buy | 8,500 | $0 |
| 2026-04-06 | Milanova Tsveta | Chief Commercial Officer | Buy | 8,500 | $0 |
| 2026-04-06 | Viswanadhan Krishnan | Chief Corp Dev & Strategy | Buy | 8,100 | $0 |
| 2026-04-06 | Goff Brian | Chief Executive Officer | Sell | 12,472 | $432,903 |
| 2026-04-06 | Jones Cecilia | Chief Financial Officer | Sell | 3,141 | $109,024 |
| 2026-04-06 | Gheuens Sarah | Chief Medical Officer | Sell | 2,940 | $102,047 |
| 2026-04-06 | Burns James William | Chief Legal Officer | Sell | 3,280 | $113,849 |
| 2026-04-06 | Milanova Tsveta | Chief Commercial Officer | Sell | 3,262 | $113,224 |
Source: SEC Form 4 filings · as of 2026-08-06